Insiders Ironwood Pharmaceuticals, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:29:51 2024-05-09 am EDT			5-day change	1st Jan Change
6.705 ^USD	-17.43%		-17.89%	-40.43%

03:55pm	Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut	MT
01:22pm	(IRWD) IRONWOOD PHARMACEUTICALS Expects Fiscal Year 2024 Revenue Range $405M - $425M	MT

Ironwood Pharmaceuticals Insider Sold Shares Worth $2,699,979, According to a Recent SEC Filing	Feb. 15	MT
Ironwood Pharmaceuticals Insider Sold Shares Worth $588,538, According to a Recent SEC Filing	Feb. 15	MT
Ironwood Pharmaceuticals Insider Sold Shares Worth $722,071, According to a Recent SEC Filing	Feb. 15	MT
Ironwood Pharmaceuticals Insider Bought Shares Worth $300,119, According to a Recent SEC Filing	23-09-18	MT
Abivax appoints head of investor relations	23-08-24	CF
Insider Sell: Ironwood Pharmaceuticals	23-06-01	MT
Ironwood Pharmaceuticals, Inc. Announces the Eliminate of Jason Rickard as Senior Vice President, Chief Operating Officer, Effective May 12, 2023	23-04-11	CI
Insider Sell: Ironwood Pharmaceuticals	23-03-29	MT
Insider Sell: Ironwood Pharmaceuticals	23-01-09	MT
Insider Sell: Ironwood Pharmaceuticals	22-12-16	MT
Insider Sell: Ironwood Pharmaceuticals	22-10-05	MT
Insider Sell: Lantheus Holdings	22-09-08	MT
Insider Sell: Ironwood Pharmaceuticals	22-09-06	MT
Insider Sell: Ironwood Pharmaceuticals	22-08-15	MT
Insider Sell: Ironwood Pharmaceuticals	22-08-11	MT
Insider Sell: Ironwood Pharmaceuticals	22-08-03	MT
Insider Sell: Ironwood Pharmaceuticals	22-06-09	MT
Insider Sell: Ironwood Pharmaceuticals	22-05-25	MT
Insider Sell: Ironwood Pharmaceuticals	22-03-16	MT
Insider Sell: Ironwood Pharmaceuticals	21-12-23	MT

No results for this search